INSIGHTS ON DRUG DEVELOPMENT
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Modeling Colorectal Cancer Progression
Gain a better understanding of the microenvironment's role in colorectal cancer progression by reviewing the integration of Organ-Chip models with high-content imaging and mass spectrometry-based metabolomics.
-
The Analytical Advantage Across The Development Lifecycle
Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.
-
Overcoming API Constraints And Tight Timelines With On-Demand Manufacturing
Use innovative lipid-based formulations and on-demand manufacturing to accelerate Phase 1 trials, enable flexible dose escalation, and maximize limited API for poorly soluble compounds.
-
Accelerating Small Molecule Development With Cutting-Edge Technology3/12/2026
Discover Asymchem Sandwich, our advanced small molecule facility at Discovery Park, Kent.
-
Injection Site Reaction Screening Methodology6/6/2025
Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.
-
Simplify Process Scale-Up With An Innovative Single-Use Bioreactor10/15/2025
Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.
-
Sterilization Of APIs – The Alternative: Sterile Filtration Following Aseptic Processing5/21/2026
When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.
-
Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery6/3/2025
Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.
DRUG DEVELOPMENT SOLUTIONS
-
SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
Used Carl Zeiss Microscope, with AxioCam MRc5 and H.I.P controls, CE design, serial# 39180008000.
-
Leica DM3000
Enhance Laboratory Workflow
The Leica DM3000 microscopes for pathology, cytology, haematology and many other applications feature a motorized nosepiece, condenser head, automated light intensity adjustment, and optional foot pedal. These intuitive microscopes improve workflows significantly. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
Guided by Quality by Design (QbD) principles, our experienced scientists develop tailored strategies that optimize product performance, manufacturability, stability, and regulatory readiness across all stages of development.